bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Here’s What Happened

bioMerieux (OTCMKTS:BMXMF) shares gapped up prior to trading on Friday . The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00, with a volume of 1,012 shares traded.

Analyst Ratings Changes

Separately, BNP Paribas Exane lowered shares of bioMerieux to a “neutral” rating in a research note on Wednesday, January 28th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

bioMerieux Price Performance

The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average price of $120.59 and a 200 day moving average price of $128.15.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.